News Focus
News Focus
Followers 129
Posts 3201
Boards Moderated 0
Alias Born 08/24/2015

Re: chinatown1980 post# 71316

Friday, 08/26/2016 1:05:29 PM

Friday, August 26, 2016 1:05:29 PM

Post# of 819726
There must be a disconnect between what you know and what you think you know. Salaries for the Vice President of a biotech with the IP owned by NWBO should be much more than $400K. The state of the PPS has nothing to do with compensation as it varies.

Juno, who has a much larger corporate structure in place, no revenues, and only possible future profits as well, pays much more. So before you claim I'm "ignorant" look in the mirror:

http://www1.salary.com/JUNO-THERAPEUTICS-INC-Executive-Salaries.html


Name/Title Total Cash Equity Other Total Compensation
Hans E. Bishop
President, Chief Executive Officer and Director $850,000 $4,449,326 $0 $5,299,326
Mark W. Frohlich M.D.
Executive Vice President, Portfolio Strategy $560,000 $1,604,890 $0 $2,164,890
Steven D. Harr M.D.
Chief Financial Officer and Head of Corporate Development $720,000 $2,701,300 $0 $3,421,300
Robert Azelby
Executive Vice President, Chief Commercial Officer $896,834 $8,609,646 $406,108 $9,912,588
Hyam Levitsky M.D.
Executive Vice President, Research and Chief Scientific Officer $831,282 $13,267,750 $43,460 $14,142,492
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News